Celestica Raises $3.39 Billion in Secondary Offering, Underwriters Exercise Full Greenshoe
The Ontario-based electronics manufacturer sold 11.1 million shares at $310 apiece to fund capital expenditures and working capital as insider sales continue.
Major Capital Raise
Celestica Inc. disclosed in an 8-K filing that it has completed a secondary offering totaling approximately $3.39 billion in net proceeds, marking one of the largest equity raises in the company's history. The Ontario-based electronics manufacturing services provider sold 9,677,419 common shares at an offering price of $310.00 per share on August 5, 2026 (8-K filing, 2026-08-07).
The underwriters—led by Citigroup Global Markets Inc., BofA Securities, Inc., and TD Securities Inc.—exercised their full greenshoe option on August 6, purchasing an additional 1,451,612 shares at the same $310 offering price (8-K filing, 2026-08-07). The total offering comprised 11,129,031 shares when including the over-allotment.
Substantial Discount to Market
The $310 offering price represents a significant discount to Celestica's recent trading levels, with the stock closing at $443.51 prior to the announcement. The pricing gap—approximately 30% below the last close—reflects standard practice for large secondary offerings but indicates substantial dilution for existing shareholders at current market valuations.
The company's market capitalization of approximately $36 billion suggests the offering represents roughly 9.4% of enterprise value, a material equity issuance by any measure.
Use of Proceeds
Celestica stated it "intends to use the net proceeds of the Offering for working capital and to support investments in capital expenditures, in addition to other general corporate purposes" (8-K filing, 2026-08-07). The filing provided no additional detail on specific projects, acquisition targets, or capacity expansion plans driving the capital need.
The $3.39 billion net proceeds figure accounts for "underwriting discounts and commissions and estimated offering expenses payable by the Company" (8-K filing, 2026-08-07), though the filing did not disclose the specific fee structure.
Regulatory Structure
The offering was conducted through a dual-listing structure, utilizing both U.S. and Canadian prospectuses. In the United States, the sale proceeded under a Form S-3 shelf registration (No. 333-285515) filed March 3, 2025. In Canada, the company filed a short form base shelf prospectus across all provinces and territories under the National Instrument 44-101 framework (8-K filing, 2026-08-07).
The underwriting agreement contained "customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933" (8-K filing, 2026-08-07).
Context and Upcoming Events
According to MarginX data, multiple lock-up agreements covering common shares, restricted share units, and deferred share units are scheduled to expire on October 5, 2026, potentially adding supply pressure approximately two months following this offering.
Recent insider activity shows Robert Mionis conducting three separate sales totaling 17,459 shares, per MarginX data, though the timing and pricing of those transactions were not disclosed in the filing.
The filing made no mention of strategic rationale beyond the general corporate purposes language, leaving investors to await management commentary on conference calls or investor presentations for additional context on the capital deployment strategy.
This article was generated by MarginX from the 8-K filing on 2026-08-07. It is not investment advice.